FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
This article was originally published in The Gray Sheet
Executive Summary
The House Energy & Commerce Committee will review FDA's conflict-of-interest procedures as part of an expanding probe that originally focused on National Institutes of Health employee consulting arrangements